COVID-19 vaccine patents: to waive or not to waive?

Research output: Contribution to journal › Article › Professional

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

HEROS: Health Emergency Response in Interconnected Systems
Kovacs, G. (Project coordinator), Falagara Sigala, I. (Project participant), Hamid Abakar, A. (Project participant) & Sarker, S. (Project participant)
01.04.2020 → 31.05.2023
Project: Externally funded project
FAirness, Morality and Equality in international and European Intellectual Property Law (FAME-IP)
Lee, N. (Project participant), Jongsma, D. (Project participant), Bruun, N. (Project participant), Cadillo Chandler, D. (Project participant), Antikainen, M. (Project participant), Kallio, S. (Project participant), Kur, A. (Project participant), Sandeen, S. (Project participant), Simon, D. (Project participant) & Calboli, I. (Project participant)
Academy of Finland
01.07.2018 → 31.12.2022
Project: Externally funded project

@article{4157339269e048a19ca1e32b606cb285,

title = "COVID-19 vaccine patents: to waive or not to waive?",

keywords = "513 Law, patentit",

author = "Nari Lee and Gy{\"o}ngyi Kovacs",

year = "2021",

month = may,

day = "10",

language = "English",

volume = "2021",

journal = "IPR-Info",

issn = "1799-909X",

publisher = "IPR University Center Association",

number = "3",

}